1-4 of 4
head and neck tumors
Close
Sort by
Journal Articles

Supplementation with Selenium As Prevention for the Development of Mucositis in Patients Undergoing HSCT. Results of a Pilot Study

Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD, Cesar Homero Gutierrez Aguirre, MD, Consuelo Mancias, MD, Luz del Carmen Tarín Arzaga, MD, Andrés Gómez-De León, MD, Miguel Herrera-Rojas, MD, Lourdes Garza-Ocañas, MD, Jose Angel Hawing, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3363.
https://doi.org/10.1182/blood-2018-99-119959
Published: 2018
Journal Articles

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Siliang Chen, Zheyuan Qin, Stephen Liang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5903.
https://doi.org/10.1182/blood-2018-99-118481
Published: 2018
Journal Articles

The Clinical Course of Head and Neck Cancer in Patients with Chronic Lymphocytic Leukemia

Aaron D Maybury, Ephraim P. Hochberg, MD, Lori J Wirth, MD, Jeremy S. Abramson, MD, Kevin S Emerick, MD, James S. Michaelson, PhD, Christiana E. Toomey, Kristina Cibor, Brad Diephuis, Devon Bush
Journal: Blood
Blood (2011) 118 (21): 4741.
https://doi.org/10.1182/blood.V118.21.4741.4741
Published: 2011
Journal Articles

ERBB Signaling Promotes BCR-Abl Expression and Modulates Multiple Signaling Pathways as Assessed by High-Throughput, Reverse Phase Protein Array.

Laura D. Nelson, PhD, Doris R. Siwak, PhD, Yiling Lu, PhD, Claudia Miller, MS, Joya Chandra, PhD, Dennis P.M. Hughes, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4349.
https://doi.org/10.1182/blood.V108.11.4349.4349
Published: 2006